The CLIA Waived Drug Test Cup is a preliminary screening test for the presence of drugs. The CLIA Waived Drug Test Cup is a qualitative, immunoassay urine-based, rapid test that incorporates collection of a urine specimen and the testing of multiple drugs simultaneously. For a quantitative result or to confirm a presumptive positive screen, a second, alternative chemical method should be performed on the same urine sample. Liquid Chromatography/Tandem Mass Spectrometry (LC-MS/MS) or Gas Chromatography/Mass Spectrometry (GC/MS) are the preferred confirmation methods.
The ‘Cutoff Level’ is the concentration level established as a break-point or threshold for labeling a result positive or negative (e.g. 50 ng/mL THC or 150 ng/mL COC). The concentration of a drug is expressed in nanograms (ng) per milliliters (mL) or ng/mL. One nanogram is equal to one billionth of a gram and 1mL is equal to about 1/30 of a fluid ounce.
|AMP||Amphetamine||500 ng/ml or 1000 ng/ml|
|COC||Cocaine||150 ng/ml or 300 ng/ml|
|EDDP||Methadone Metabolite||300 ng/ml|
|EtG||Ethyl Glucuronide||300 ng/ml|
|K2/Spice||Synthetic Marijuana||20 ng/ml|
|MET||Methamphetamine||500 ng/ml or 1000 ng/ml|
|OPI||Opiates||300 ng/ml or 2000 ng/ml|
|TCA||Tricyclic antidepressants||1,000 ng/ml|